Autonomix Medical Selected for Featured Podium Presentation at SIR 2026

Autonomix Medical, Inc. (NASDAQ: AMIX) announced that its research abstract has been selected for a featured podium presentation at the Society of Interventional Radiology (SIR) 2026 Annual Scientific Meeting. The research focuses on long-term pain mitigation in pancreatic cancer patients using the company's transvascular RF energy-based ablation technology. This precision nerve-targeted approach aims to provide a significant breakthrough in managing chronic cancer-related pain. The selection highlights the clinical relevance and potential of Autonomix's technology within the specialized medical community. For a small-cap medical device firm, such recognition at a major scientific conference provides essential clinical validation and increased visibility. Investors typically view these milestones as positive indicators of the company's progress toward broader commercial and regulatory acceptance.